Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | -0.25% | -20.63% | +20.48% |
05-16 | UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating | MT |
05-07 | HC Wainwright Adjusts Price Target on Rani Therapeutics Holdings to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.48% | 105M | |
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- RANI Stock
- News Rani Therapeutics Holdings, Inc.
- UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating